What has changed this respiratory season—and what do pediatric practices actually need to know? In this episode of Cumberland Conversations: Journal Club, Dr. Caitlin Newhouse, Medical Director for the Vaccine-Preventable Diseases and Immunization Program under the Tennessee Department of Health, joins us for a practical look at the latest vaccine and immunization considerations facing pediatric practices as respiratory illness season gets underway. The conversation begins with influenza, including vaccine timing, avoiding missed opportunities, communicating realistic expectations with families, and several questions that continue to come up in practice. We also discuss how practices can use reminders, outreach, and routine visits to improve vaccination opportunities throughout the season. From there, the discussion turns to RSV prevention, where changing options have created new questions for pediatricians and families. Dr. Newhouse walks through important considerations surrounding infant eligibility, maternal vaccination, prior RSV infection, timing, and some of the real-world access and implementation challenges that can complicate what appears straightforward on paper. We also examine the evolving COVID-19 vaccine landscape for children, including access through the Vaccines for Children program, pediatric risk considerations, vaccination goals, and the importance of setting appropriate expectations about protection from severe disease. Along the way, the conversation touches on disease surveillance, vaccine-preventable illnesses including measles, and the operational realities practices face when recommendations, availability, and patient questions are all changing at the same time. For pediatric providers and practice teams heading into respiratory season, this episode helps translate recommendations into the questions that come up in the exam room—and the decisions practices have to make behind the scenes. Key TakeawaysFlu vaccination may feel familiar, but some of the details still deserve a closer look. Hear what Dr. Newhouse says about timing, missed opportunities, common patient questions, and setting expectations about what influenza vaccination can—and cannot—do.RSV prevention is no longer a one-size-fits-all conversation. The episode works through some of the questions practices may encounter when considering infant protection, maternal vaccination, previous infection, eligibility, and timing.The recommendation may be straightforward; implementing it often isn’t. Hear how availability, cost, VFC participation, birthing-hospital practices, and the transition from hospital to pediatric office can influence whether children actually receive recommended protection.COVID vaccination in pediatrics continues to require context. Dr. Newhouse discusses access, pediatric risk, uptake, and why conversations with families may need to focus less on preventing every infection and more on the outcomes vaccination is intended to improve.Respiratory-season planning is also a practice workflow issue. The conversation explores how outreach, reminders, routine visits, and reducing missed opportunities can help turn recommendations into actual patient care.And respiratory viruses aren’t the only vaccine-preventable diseases practices need on their radar. Hear how current disease activity and outbreaks—including measles—fit into the broader immunization conversation.To read the full articles referenced in this podcast episode, please see the URLs below. Please Note: articles may be restricted to authorized access via subscription or membership to the Journal or the Journal's owner entity. AAP Committee on Infectious Diseases. Recommendations for Prevention and Control of Influenza in Children, 2026–2027: Policy Statement. Pediatrics. 2026; doi: 10.1542/peds. 2026-078778 RSV Immunization Administration: Visual Guide American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Policy Statement. Pediatrics. 2026; doi: 10.1542/peds.2026-079045 American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the Prevention of Respiratory Syncytial Virus Disease in Infants and Children: Policy Statement. Pediatrics. 2026; doi: 10.1542/peds.2026-079047